Search
Find a recruiting study
7,114 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 28, 2026). No sign-up needed.
Most recently updated studies · page 92 of 297
- RecruitingPhase 2
A Phase 2A Trial of DT402 for Autism Spectrum Disorder
Definium Therapeutics US, Inc.
- Location
- New York, NY
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Pulmovant, Inc.
- Location
- Santa Barbara, CA + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Inhibikase Therapeutics
- Location
- Scottsdale, AZ + 14 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD
Scholar Rock, Inc.
- Location
- Austin, TX
- Eligibility basics
- Ages 18–60
- RecruitingPhase 1
Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue
Ayu, Inc.
- Location
- Phoenix, AZ
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild iDFU
Lakewood-Amedex Inc
- Location
- Los Angeles, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
AstraZeneca
- Location
- Sacramento, CA + 6 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma
Aspeya, Inc.
- Location
- Anaheim, CA
- Eligibility basics
- Ages 18–55
- RecruitingPhase 2
Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
Lexeo Therapeutics
- Location
- Tampa, FL
- Eligibility basics
- Ages 6+
- RecruitingPhase 1/Phase 2
FT839 in Autoimmune Diseases
Fate Therapeutics
- Location
- Fullerton, CA
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Vertex Pharmaceuticals Incorporated
- Location
- Duarte, CA + 9 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Chronic Evaluation of Novel Pacemaker System
Calyan Technologies
- Location
- Minneapolis, MN
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
AbbVie
- Location
- Little Rock, AR + 11 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 2
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Zydus Therapeutics Inc.
- Location
- La Jolla, CA + 13 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
Kuros Biosurgery AG
- Location
- Sacramento, CA + 6 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
EFS of Posterior Leaflet Replacement to Reduce Mitral Regurgitation (United States)
Polares Medical SA
- Location
- Atlanta, GA
- Eligibility basics
- Ages 21+
- RecruitingPhase 2
DB-3Q for the Treatment of Medically Refractory Crohn's Disease
Direct Biologics, LLC
- Location
- St Louis, MO
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)
Kriya Therapeutics, Inc.
- Location
- Lady Lake, FL
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and…
Novo Nordisk A/S
- Location
- Fairhope, AL + 55 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 2/Phase 3
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
Quoin Pharmaceuticals
- Location
- San Diego, CA + 2 other US sites
- Eligibility basics
- Ages 14+
- RecruitingPhase 1/Phase 2
Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy
CytoAgents, Inc.
- Location
- Orange, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of AMDX-2011P in Participants With Alzheimer's Disease
Amydis Inc.
- Location
- Phoenix, AZ
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Quoin Pharmaceuticals
- Location
- Chicago, IL
- Eligibility basics
- Ages 14+
- Recruiting
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
Teleflex
- Location
- Washington D.C., DC + 1 other US site
- Eligibility basics
- Ages 18–80
Data source: daily sync of the ClinicalTrials.gov API. How we list studies